ClinicalTrials.Veeva

Menu

Confinement and Spondyloarthritis Treatment

C

Centre Hospitalier Universitaire de Nice

Status

Unknown

Conditions

Spondyloarthritis

Study type

Observational

Funder types

Other

Identifiers

NCT04355923
20rhumatocovid01

Details and patient eligibility

About

Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • spondyloarthritis,
  • age over 18 ans
  • treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).

Trial contacts and locations

1

Loading...

Central trial contact

Christian Roux, MD, PhD; Olivier BROCQ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems